Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02273076

Predicting Breast Flap Necrosis by Spatial Frequency Domain Imaging

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The current surgical procedure for breast diseases places an emphasis on the conservation of breast skin in order to provide more optimal reconstruction. The purpose of this study is to use portable, non-contact optical imaging device developed at the Beckman Laser Institute called Spatial Frequency Domain Imaging to detect the changes in a skin during reconstructive surgery procedure and healing process.

Detailed description

The researchers can use Spatial Frequency Domain Imaging instrument to measure the concentration of blood flow in the skin tissue and can determine of the changes that observed in the properties of the mastectomy flap that may be delay in healing process. The imaging device can determine the change from baseline measurement to the development of skin necrosis, wound infection, or implant extrusion.

Conditions

Interventions

TypeNameDescription
DEVICESpatial Frequency Domain ImagingSpatial Frequency Domain Imaging

Timeline

Start date
2014-10-01
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2014-10-23
Last updated
2022-11-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02273076. Inclusion in this directory is not an endorsement.

Predicting Breast Flap Necrosis by Spatial Frequency Domain Imaging (NCT02273076) · Clinical Trials Directory